004310.KS KSC
Hyundai Pharmaceutical Co., Ltd.
1W: -5.9%
1M: +0.6%
3M: +48.9%
YTD: -33.7%
1Y: +117.2%
3Y: +115.3%
5Y: +19.9%
₩8,340.00 ($6.20)
-140.00 (-1.65%)
Weekly Expected Move ±14.4%
₩5935
₩7137
₩8340
₩9543
₩10745
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$123M
+94.8% ▲
Capital Expenditures
$4.6B
+58.8% ▲
5Y CAGR: -6.4%
Free Cash Flow
-$4.7B
+65.1% ▲
Dividends Paid
$784M
+15.1% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$7.8B
-31.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3.2B | -$165M | $6.1B | -$575M | $2.5B |
| Depreciation & Amort. | $4.0B | $3.3B | $3.3B | $3.7B | $4.3B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$600M | $1.7B | -$28.2B | -$7.5B | -$9.4B |
| Other Non-Cash Items | $4.9B | $6.7B | $14.3B | $2.0B | $2.5B |
| Operating Cash Flow | $5.1B | $11.6B | -$4.5B | -$2.4B | -$123M |
| — Investing Activities — | |||||
| Capital Expenditures | -$6.8B | -$6.6B | -$6.1B | -$9.8B | -$5.9B |
| Acquisitions (Net) | -$5.5B | $7M | $0 | $0 | $16M |
| Investment Purchases | -$10.0B | -$3.7B | -$4.0B | -$46.7B | -$41.6B |
| Investment Sales | $16.7B | $291M | $4.5B | $48.2B | $39.1B |
| Other Investing | $5.5B | $35M | $2.5B | -$1.3B | $38M |
| Investing Cash Flow | -$28M | -$10.0B | -$3.1B | -$9.7B | -$8.4B |
| — Financing Activities — | |||||
| Net Debt Issuance | $5.0B | $10.0B | -$1.0B | $9.6B | $1.9B |
| Stock Repurchased | $0 | -$1.5B | -$3.8B | -$2.1B | $0 |
| Dividends Paid | -$1.2B | -$836M | -$826M | -$923M | -$784M |
| Other Financing | -$564M | -$632M | -$799M | -$532M | -$414M |
| Financing Cash Flow | $3.3B | $7.0B | -$6.4B | $6.1B | $721M |
| Net Change in Cash | $8.4B | $8.6B | -$14.1B | -$5.9B | -$7.8B |
| Cash End of Period | $21.6B | $30.3B | $16.2B | $10.3B | $2.5B |
| Free Cash Flow | -$1.7B | $5.0B | -$10.6B | -$13.6B | -$4.7B |